The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • BPH Energy’s (BPH) investee company, Cortical Dynamics, has filed a new international patent application for measuring brain activity
  • The new application titled, “Apparatus and process for measuring brain activity,” will ensure that any intellectual property will be protected during commercialisation
  • Cortical’s current primary product is the Brain Anaesthesia Response Monitor which has been developed to better detect the effect of anaesthesia on brain activity
  • It improves on the currently used electroencephalogram technologies by incorporating the latest advances in technology
  • Cortical has already received 22 patents spanning throughout Australia, New Zealand, Chain, Japan, Europe, and the United States
  • Despite this news, BPH Energy is down 8.70 per cent on the market and shares are trading for 2.1 cents each

BPH Energy’s (BPH) investee company, Cortical Dynamics, has filed a new international patent application for measuring brain activity.

The new application is titled “Apparatus and process for measuring brain activity” and will ensure that any intellectual property will be protected during commercialisation.

Cortical’s current primary product is the Brain Anaesthesia Response Monitor (BARM), which has been developed to better detect the effect of anaesthesia on brain activity.

It improves on the currently used electroencephalogram (EEG) technologies by incorporating the latest advances in technology and understanding in the brain’s electrical activity.

An EEG is used to test and record brain activity and does so by attaching small metal discs to the patient’s head.

It can determine changes in brain activity, detect epilepsy, diagnose brain disorders, and sleep disorders.

It can also be used to determine the right level of anaesthesia for a patient in a medically induced coma.

According to Cortical, BARM is “fundamentally different” to all other current devices, as it’s able to detect a range of sedative and anaesthetic medications, such as ketamine and nitrous oxide.

Further, it can detect the effects of hypnotic and analgesic (pain-relieving) agents.

Cortical has already received 22 patents, spanning throughout Australia, New Zealand, Chain, Japan, Europe, and the United States.

Despite this news, BPH Energy is down 8.70 per cent on the market and shares are trading for 2.1 cents each at 2:16 pm AEST.

bph by the numbers
More From The Market Online

Pro Medicus signs $43M, seven-year contract with Virtua Health in US

Pro Medicus' wholly-owned US subsidiary, Visage Imaging, has signed a seven-year, $43 million contract with Virtua…

Recce welcomes positive phase 3 clinical trial data for topical gel for diabetic foot ulcer infections

Recce Pharmaceuticals has reported a review of blinded data of its current phase 3 trial has…

Infocus Group’s gaming subsidiary signs $2.4M minimum first contract

InFocus Group's subsidiary InFocus Gaming Technologies has signed a binding conditional agreement with its first customer…
A computer chip

Weebit Nano jumps +15% on Sept quarterly as second customer takes up ReRAM but shares well off June peak

Weebit Nano (ASX:WBT)